Insider Shareholders with Direct Ownership of Galectin Therapeutics Inc (GALT)
This section provides a comprehensive overview of the insiders with direct ownership of Galectin Therapeutics Inc (GALT). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
GALECTIN THERAPEUTICS INC Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 2,345,693 | 0 | 10,301,271 $56.7 Million | 5 |
Jan 23, 2025
Added 0.31%
|
|
|
10 X Fund, L.P.
> 10% Shareholder |
0 | 482,181 | 5,614,457 $30.9 Million | 26 |
Dec 16, 2025
Reduced 0.54%
|
|
James C Czirr
> 10% Shareholder |
324,125 | 20,000 | 1,045,541 $5.75 Million | 4 |
Jun 06, 2025
Added 3.68%
|
|
Joel Lewis
President and CEO |
1,126,946 | 402,612 | 832,592 $4.58 Million | 102 |
Dec 17, 2025
Reduced 0.93%
|
| 21,167 | 0 | 65,382 $359,601 | 8 |
Dec 23, 2025
Added 1.06%
|
|
| 0 | 60,000 | 60,614 $333,377 | 1 |
Jan 11, 2021
Reduced 49.75%
|
|
| 31,800 | 0 | 55,269 $303,979 | 7 |
Dec 23, 2025
Added 9.05%
|
|
| 27,500 | 0 | 42,083 $231,456 | 6 |
Dec 24, 2024
Added 19.2%
|
|
|
Jack W Callicutt
Chief Financial Officer |
168,956 | 164,956 | 7,614 $41,877 | 17 |
Nov 18, 2025
Reduced 70.52%
|
| 226,500 | 228,499 | 6,500 $35,750 | 11 |
Dec 17, 2025
Reduced 42.0%
|
|
| 1,000 | 0 | 1,000 $5,500 | 1 |
Jan 21, 2022
Added 50.0%
|
|
|
Khurram Jamil
Chief Medical Officer |
154,213 | 154,213 | 0 $0 | 6 |
Dec 17, 2025
Reduced 100.0%
|